Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç÷°ü³» ¹æ»ç¼±Ä¡·á¸¦ À§ÇÑ ÀÌ·ÐÀû ¼±¿ø ¼³°è ¹× ¼±·®Àû °üÁ¡¿¡¼­ÀÇ ÀûÇÕ¼º ¿¬±¸: Ãâ·Âº¯Á¶¸¦ ÀÌ¿ëÇÑ ±ÙÁ¢Ä¡·á¿¡ ´ëÇÑ Á¦¾È Conceptual Source Design and Dosimetric Feasibility Study for Intravascular Treatment: A Proposal for Intensity Modulated Brachytherapy

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2003³â 21±Ç 2È£ p.158 ~ 166
¼Ò¼Ó »ó¼¼Á¤º¸
±è½Ã¿ë/Si Yong Kim ÇÑÀº¿µ/Hatinder R Palta/ÇϼºÈ¯/Eun Young Han/Jatinder R Palta/Sung W Ha

Abstract

¸ñÀû: º» ¿¬±¸´Â »õ·Î¿î ±ÙÁ¢Ä¡·á¼±¿øÀÇ ÀÌ·ÐÀû ¼³°è¸¦ ÅëÇØ Ãâ·Âº¯Á¶¸¦ ÀÌ¿ëÇÑ Ç÷°ü³» ¹æ»ç¼±Ä¡·á¸¦ Á¦¾ÈÇÑ´Ù. ´ë»ó ¹× ¹æ¹ý: Á¦½ÃµÈ ÀÌ·ÐÀû ¼±¿øÀº ±âÁ¸ÀÇ ¼±¿ø°ú´Â ´Þ¸® ¼±¿ø¹°Áú°ú Â÷Æó¹°Áú(½ºÅ×Àθ®½º ½ºÆ¿, ¶Ç´Â ÅÖ½ºÅÙ) µÑ ´Ù·Î ±¸¼ºµÇ¸ç ÀÌ´Â ¹æÀ§¹æÇâÀ¸·Î
ºñ´ëĪÀû ¹æ»ç¼±·®À» Á¦°øÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. µû¶ó¼­, ¹æÀ§¹æÇâÀ¸·Î ¼±¿øÀÇ ¹æÇâ°ú ü·ù½Ã°£À» Á¶ÀýÇÔÀ¸·Î½á Ãâ·Âº¯Á¶¸¦ ÅëÇÑ ±ÙÁ¢Ä¡·á°¡ °¡´ÉÇØÁø´Ù. Novoste Beta-Cath system¿¡¼­ »ç¿ëÇÏ´Â Sr-90/Y ÀüÀÚ¹æÃâ ¼±¿ø°ú À¯»çÇÑ ¸ð¾çÀÇ µÎ °¡Áö ´Ü¼øÈ­ÇÑ ¼±¿øÀ» ¿¬±¸ÀÇ
´ë»óÀ¸·Î °í·ÁÇÏ¿´´Ù. ù ¹ø° ¼±¿øÀº ¼±¿ø¹°Áú°ú Â÷Æó¹°ÁúÀÌ °¢°¢ ¹Ý¾¿ Â÷ÁöÇϸç, µÎ ¹ø° ¼±¿øÀº 1/4Àº ¼±¿ø¹°Áú·Î, ³ª¸ÓÁö 3/4Àº Â÷Æó¹°Áú·Î ±¸¼ºµÈ´Ù. µÎ ¼±¿ø¿¡ ´ëÇØ ¹æÀ§ ¹× ¹æ»ç¹æÇâÀ¸·ÎÀÇ ¼±·®ºÐÆ÷¸¦ MCNP ¸óÅ× Ä«¸¦·Î Äڵ带 ÀÌ¿ëÇÏ¿© °è»êÇÏ¿´´Ù. °á°ú: ¼±¿øÀÌ
Ç÷°ü³»ÀÇ Á߽ɿ¡ À§Ä¡ÇÏÁö ¾Ê°Ô µÇ´Â °¡»óÁ¶°Ç¿¡¼­ÀÇ ¼±·® ÃÖÀûÈ­ °è»êÀ» ½ÃµµÇÑ °á°ú, Ç÷°ü³»º®¿¡ ¹ÌÄ¡´Â ¼±·®ÀÇ ÃÖ°íÄ¡¿Í ÃÖÀúÄ¡ÀÇ Â÷ÀÌ°¡ 87%¿¡¼­ 7%±îÁö ÁÙ¾îµé ¼ö ÀÖÀ½À» º¸¿´´Ù. °á·Ð: º» ¿¬±¸¿¡¼­ Á¦½ÃµÈ ÀÌ·ÐÀû ¼±¿øÀº ¼±·®Àû °üÁ¡¿¡¼­ÀÇ ÀûÇÕ¼º ¿©ºÎ¿¡ °üÇØ ¸Å¿ì
°í¹«ÀûÀÎ °á°ú¸¦ º¸¿© ÁÜÀ¸·Î½á Ãâ·Âº¯Á¶¸¦ ÅëÇÑ Ç÷°ü³» ±ÙÁ¢¹æ»ç¼±Ä¡·áÀÇ °¡´É¼ºÀ» ³ªÅ¸³»¾ú´Ù. º» °úÁ¦ÀÇ ´ÙÀ½ ´Ü°è´Â ±½±â°¡ °¡´Â ¸Æ°ü ³»¿¡¼­ ¼±¿øÀÇ À§Ä¡¸¦ ÆľÇÇÏ¿© ±×¸¦ ¹æÀ§¹æÇâÀ¸·Î Á¤È®ÇÏ°Ô È¸Àü½Ãų ¼ö ÀÖ´Â ¹æ»ç¼± Àü´Þ ü°èÀÇ °³¹ßÀ̶ó ÇÒ ¼ö ÀÖ´Ù.

PURPOSE: To propose a conceptual design of a novel source for intensity modulated brachytherapy. MATERIALS AND METHODS: The source design incorporates both radioactive and shielding materials (stainless steel or tungsten), to provide an asymmetric dose
intensity in the azimuthal direction. The intensity modulated intravascular brachytherapy was performed by combining a series of dwell positions and times, distributed along the azimuthal coordinates. Two simple designs for the beta-emitting sources,
with similar physical dimensions to a (90)Sr/Y Novoste Beat-Cath source, were considered in the dosimetric feasibility study. In the first design, the radioactive and materials each occupy half of the cylinder and in the second, the radioactive material
occupies only a quater of the cylinder. The radial and azimuthal dose distributions around each source were calculated using the MCNP Monte Carlo code. RESULTS: The preliminary hypothetical simulation and optimization results demonstrated the 87%
difference between the maximum and minimum doses to the lumen wall, due to off-centering of the radiation source, could be reduced to less than 7% by optimizing the azimuthal dwell positions and times of the partially shielded intravascular
brachytherapy sources. CONCLUSION: The novel brachytherapy source design, and conceptual source delivery system, proposed in this study show promising dosimetric characteristics for the realization of intensity modulated brachytherapy in intravascular
treatment. Further development of this concept will center on building a delivery system that can precisely control the angular motion of a radiation source in a small-diameter catheter.

Å°¿öµå

Ãâ·Âº¯Á¶; Ç÷°ü³» ±ÙÁ¢Ä¡·á; MCNP; Intensity modulation; Intravascular brachytherapy; MCNP;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS